Cv Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cv Sciences Inc inventory turnover ratio, the Cv Sciences Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.45 in the second quarter 2026, CVSI's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Cv Sciences Inc in Jun 30 2026 quarter, has decreased to 252 days, compare to 283 days, in the Mar 31 2026 quarter.

Within Healthcare sector 279 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1829 in the first quarter 2026, to 1865.

CVSI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cv Sciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CVSI Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-5.95 %	-10.67 %	-16.54 %	-18.73 %	-19.02 %
Y / Y Cost of Sales Growth	53.5 %	63.3 %	-18.2 %	-50 %	-50 %
Inventory Turnover Ratio (TTM)	1.45	1.29	1.11	1.14	1.3
CVSI's Total Ranking	# 1865	# 1829	# 1805	# 1962	# 1850
Average inventory processing period	252	282	330	320	281
Seq. Inventory Growth	1.61 %	-4.53 %	0.17 %	-3.23 %	-3.48 %
Seq. Cost of Sales Growth	-6 %	-0.18 %	63.6 %	0 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 78
Healthcare Sector	# 280
Overall Market	# 1865

Inventory Turnover Ratio Statistics
High	Average	Low
2.89	1.35	0.25
(Sep 30 2018)		(Sep 30 2016)

CVSI Company Profile >> Back to CVSI Efficiency Comparisons >> Compare CVSI Inventory Turnover Ratio to its Competitors

Financial Statements
Cv Sciences Inc 's Inventories	$ 4 Millions	Visit CVSI's Balance sheet
Cv Sciences Inc 's Cost of Revenues TTM	$ 6 Millions	Visit CVSI's Income Statement
What are CVSI's Sales?		Visit CVSI's Sales by Segment

Other Inventory Turnover Ratios
Cv Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CVSI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CVSI's Competitors
Inventory Turnover Ratio for CVSI's Suppliers
Inventory Turnover Ratio for CVSI's Customers

You may also want to know
CVSI's Sales Growth Rates	CVSI's Pe Price to earnings ratio	CVSI's Receivables Turnover Ratio	CVSI's Stock Quote
CVSI's Net Income Growth Rates	CVSI's Ps Price to Sales ratio	CVSI's Sales per Employee	CVSI's Asset Turnover Ratio
CVSI's Net Margin	CVSI's Pb Price to Book ratio	CVSI's Financial Strength Ratios	CVSI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Solventum Corporation	3.22	$ 3,421.000 Millions	$ 1,061 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Zevra Therapeutics Inc	3.14	$ 6.180 Millions	$ 2 Millions
Prestige Consumer Healthcare Inc	3.13	$ 513.522 Millions	$ 164 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions

Date modified: 2026-09-03T11:41:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.